CARTANA

Welcome to the Brand page for “CARTANA”, which is offered here for Apparatus and instruments for scientific and diagnostic use; apparatus and instruments used for in situ rna sequencing, rna transcription profiling, detection of rna in tissue samples, microrna expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets, diagnostics, companion diagnostics; appartus and instruments for detection of gene mutation for clinical, oncology, and hematology diagnostics; apparatus, instruments and software used in scientific analysis, rna expression profiling, detection of rna, image analysis and cell segmentation for research and diagnostic use; microfluidic instruments for non-medical use; apparatus, instruments and software used in scientific analysis, rna expression profiling and detection of rna for research and diagnostic use;diagnostic reagents for medical use in the field of cancer; diagnostic reagents for clinical or medical laboratory use, for in situ rna sequencing, rna transcription profiling, detection of rna in tissue samples, microrna expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; diagnostic reagents for detection of gene mutation for clinical, oncology, and hematology diagnostics; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily of reagents, slides, solid matrix materials, microfluidic devices sold as a unit; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit; medical diagnostic reagents for in situ rna sequencing, rna transcription profiling, detection of rna in tissue samples, microrna expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; reagents for microfluidic instruments for medical use; kits for research use, diagnostics use and drug development, oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores; kits for research use, diagnostics use and drug development, oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores;chemicals used in scientific analysis, research, diagnostics and industrial use; chemicals for in situ rna sequencing, rna transcription profiling, detection of rna in tissue samples, microrna expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics; chemicals kits including oligonucleotides, reagent buffers, enzymes, detection solutions, fluorophores for research and diagnostics use and drug development purpose; reagents for microfluidic instruments for non-medical use;medical services; medical diagnostic services; veterinary services; veterinary diagnostic services;apparatus and instruments used for in situ rna sequencing, rna transcription profiling, detection of rna in tissue samples, microrna expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets, diagnostics, companion diagnostics for medical use; microfluidic instruments for medical use;research, development and diagnostics services for others regarding in situ rna sequencing, rna transcription profiling, detection of rna in tissue samples, microrna expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets; drug development; diagnostic and companion diagnostic development; data science (biostatistics) services; laboratory biomarker analysis services and related data analysis; image analysis and cell segmentation services; medical and scientific research;.

Its status is currently believed to be active. Its class is unavailable. “CARTANA” is believed to be currently owned by “CartaNA AB”.